Skip to main content
Five Big Questions Following the CME/NEX Deal Announcement
Following the announcement that CME Group is to buy OTC platform operator and post trade services provider NEX Group for $5.4 billion, Galen Stops, raises five important questions that both the parties involved in the deal, and the wider FX market, probably need to consider. Is it good value? Could there be more deals for OTC platforms? Do OTC platforms need scale to survive? Will this deal lead to more futures trading? And does this deal represent competition for LCH?

Please Log in or Register to view this content.

Access to event programmes and latest news is FREE upon registration to approved market participants. Please note that a manual approval process is in place. Registrations are approved during London and New York office hours. Click here to register

To access our full website with over 11,000 articles, please subscribe by clicking here.

Click to log in

Click to subscribe